Innovative technologies in diabetes management

Diabetes mellitus (DM) is a major global problem characterized by a steady increase in incidence and a high rate of undiagnosed cases. Epidemiological data indicate that the actual number of patients with diabetes may significantly exceed official statistics, which is also relevant for Russia. Diabetes management options are significantly expanding due to digital technologies, which create a holistic care ecosystem. Continuous glucose monitoring (CGM) systems, which allow for the assessment of glycemic variability throughout the day, play a key role. The integration of CGM with insulin pumps has led to the development of automated insulin delivery systems. These systems use algorithms to autonomously adjust insulin doses, improving glycemic outcomes and reducing patient burden. For patients on injection therapy, smart syringe pens improve adherence through reminders and accurate dose recording. Telemedicine platforms and mobile apps provide remote monitoring and consulting support, overcoming geographic barriers. In the Russian Federation, these trends are being implemented as part of government initiatives to digitalize healthcare, aimed at introducing personal monitoring devices. Along with CGM systems and automated insulin pumps, smart glucometers integrated into mobile apps are becoming an important element of the digital ecosystem. A prominent example of such a solution on the Russian market is the Glucocard Σ+ Link glucometer. This device combines high measurement accuracy with automatic data transfer via Bluetooth to the WeCheck Diabetes mobile app. This allows patients to keep an electronic self-monitoring diary, analyze trends, and remotely share results with their physician. Thus, the widespread adoption of digital solutions is a decisive factor in improving patients’ quality of life, improving clinical prognoses, and building a more effective diabetes care system.